PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Niagen Bioscience, Inc.
Filed: June 9, 2017
Period of Report: June 9, 2017
Accession Number: 0001654954-17-005482

View Document ↗ View on SEC.gov ↗